Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression

Aspergillus fumigatus is responsible for a disproportionate number of invasive mycosis cases relative to other common filamentous fungi. While many fungal factors critical for infection establishment are known, genes essential for disease persistence and progression are ill defined. We propose that fungal factors that promote navigation of the rapidly changing nutrient and structural landscape characteristic of disease progression represent untapped clinically relevant therapeutic targets. To this end, we find that A. fumigatus requires a carbon catabolite repression (CCR) mediated genetic network to support in vivo fungal fitness and disease progression. While CCR as mediated by the transcriptional repressor CreA is not required for pulmonary infection establishment, loss of CCR inhibits fungal metabolic plasticity and the ability to thrive in the dynamic infection microenvironment. Our results suggest a model whereby CCR in an environmental filamentous fungus is dispensable for initiation of pulmonary infection but essential for infection maintenance and disease progression. Conceptually, we argue these data provide a foundation for additional studies on fungal factors required to support fungal fitness and disease progression and term such genes and factors, DPFs (disease progression factors).

[1]  R. Fluhr,et al.  Carbon regulation of environmental pH by secreted small molecules that modulate pathogenicity in phytopathogenic fungi. , 2016, Molecular plant pathology.

[2]  N. Gow,et al.  The Rewiring of Ubiquitination Targets in a Pathogenic Yeast Promotes Metabolic Flexibility, Host Colonization and Virulence , 2016, PLoS pathogens.

[3]  J. Perfect,et al.  The Zinc Finger Protein Mig1 Regulates Mitochondrial Function and Azole Drug Susceptibility in the Pathogenic Fungus Cryptococcus neoformans , 2016, mSphere.

[4]  S. Krappmann,et al.  Mutant characterization and in vivo conditional repression identify aromatic amino acid biosynthesis to be essential for Aspergillus fumigatus virulence , 2016, Virulence.

[5]  R. A. Cramer,et al.  In vivo veritas: Aspergillus fumigatus proliferation and pathogenesis – conditionally speaking , 2016, Virulence.

[6]  E. Werner,et al.  ChIP-seq and In Vivo Transcriptome Analyses of the Aspergillus fumigatus SREBP SrbA Reveals a New Regulator of the Fungal Hypoxia Response and Virulence , 2014, PLoS pathogens.

[7]  Fabian Horn,et al.  FungiFun2: a comprehensive online resource for systematic analysis of gene lists from fungal species , 2014, Bioinform..

[8]  T. Hohl,et al.  Myeloid Derived Hypoxia Inducible Factor 1-alpha Is Required for Protection against Pulmonary Aspergillus fumigatus Infection , 2014, PLoS pathogens.

[9]  C. García-Estrada,et al.  Direct involvement of the CreA transcription factor in penicillin biosynthesis and expression of the pcbAB gene in Penicillium chrysogenum , 2014, Applied Microbiology and Biotechnology.

[10]  K. Kwon-Chung,et al.  Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen? , 2013, PLoS pathogens.

[11]  J. Latgé,et al.  Hypoxia enhances innate immune activation to Aspergillus fumigatus through cell wall modulation. , 2013, Microbes and infection.

[12]  N. Gow,et al.  The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans , 2012, mBio.

[13]  S. Krappmann,et al.  Deciphering metabolic traits of the fungal pathogen Aspergillus fumigatus: redundancy vs. essentiality , 2012, Front. Microbio..

[14]  R. A. Cramer,et al.  Dsc Orthologs Are Required for Hypoxia Adaptation, Triazole Drug Responses, and Fungal Virulence in Aspergillus fumigatus , 2012, Eukaryotic Cell.

[15]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[16]  Aurélien Mazurie,et al.  Transcriptomic and proteomic analyses of the Aspergillus fumigatus hypoxia response using an oxygen-controlled fermenter , 2012, BMC Genomics.

[17]  Hubertus Haas,et al.  SREBP Coordinates Iron and Ergosterol Homeostasis to Mediate Triazole Drug and Hypoxia Responses in the Human Fungal Pathogen Aspergillus fumigatus , 2011, PLoS genetics.

[18]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[19]  N. L. Glass,et al.  Identification of the CRE-1 Cellulolytic Regulon in Neurospora crassa , 2011, PLoS ONE.

[20]  Jeffrey M. Macdonald,et al.  In vivo Hypoxia and a Fungal Alcohol Dehydrogenase Influence the Pathogenesis of Invasive Pulmonary Aspergillosis , 2011, PLoS pathogens.

[21]  E. Werner,et al.  Analysis of the Aspergillus fumigatus Proteome Reveals Metabolic Changes and the Activation of the Pseurotin A Biosynthesis Gene Cluster in Response to Hypoxia , 2011, Journal of proteome research.

[22]  J. Bell,et al.  The Small GTPase RacA Mediates Intracellular Reactive Oxygen Species Production, Polarized Growth, and Virulence in the Human Fungal Pathogen Aspergillus fumigatus , 2010, Eukaryotic Cell.

[23]  J. Margareto,et al.  What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. , 2010, Revista iberoamericana de micologia.

[24]  M. Rep,et al.  Mutation of CRE1 in Fusarium oxysporum reverts the pathogenicity defects of the FRP1 deletion mutant , 2009, Molecular microbiology.

[25]  Brice Enjalbert,et al.  Glucose promotes stress resistance in the fungal pathogen Candida albicans. , 2009, Molecular biology of the cell.

[26]  M. Dunn,et al.  Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. , 2009, Microbiology.

[27]  M. Brock,et al.  Fungal metabolism in host niches. , 2009, Current opinion in microbiology.

[28]  M. Penttilä,et al.  Genetic Modification of Carbon Catabolite Repression in Trichoderma reesei for Improved Protein Production , 2009, Applied and Environmental Microbiology.

[29]  J. J. Otero,et al.  Overexpression of isocitrate lyase-glyoxylate bypass influence on metabolism in Aspergillus niger. , 2009, Metabolic engineering.

[30]  Nora Grahl,et al.  Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence. , 2009, Medical mycology.

[31]  Martin Bard,et al.  A Sterol-Regulatory Element Binding Protein Is Required for Cell Polarity, Hypoxia Adaptation, Azole Drug Resistance, and Virulence in Aspergillus fumigatus , 2008, PLoS pathogens.

[32]  Michael Bailey,et al.  Blood glucose concentration and outcome of critical illness: The impact of diabetes* , 2008, Critical care medicine.

[33]  B. Görke,et al.  Carbon catabolite repression in bacteria: many ways to make the most out of nutrients , 2008, Nature Reviews Microbiology.

[34]  U. Stenzel,et al.  PatMaN: rapid alignment of short sequences to large databases , 2008, Bioinform..

[35]  J. Musser,et al.  A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus , 2008, Proceedings of the National Academy of Sciences.

[36]  H. Virgin In vivo veritas: pathogenesis of infection as it actually happens , 2007, Nature Immunology.

[37]  D. Baines,et al.  Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis. , 2007, Journal of applied physiology.

[38]  Yi Xiong,et al.  Fusion PCR and gene targeting in Aspergillus nidulans , 2006, Nature Protocols.

[39]  J. C. Rhodes Aspergillus fumigatus: growth and virulence. , 2006, Medical mycology.

[40]  J. Latgé,et al.  Aspergillus fumigatus: saprophyte or pathogen? , 2005, Current opinion in microbiology.

[41]  J. Lopez-Ribot,et al.  Engineered Control of Cell Morphology In Vivo Reveals Distinct Roles for Yeast and Filamentous Forms of Candida albicans during Infection , 2003, Eukaryotic Cell.

[42]  A. Casadevall,et al.  The damage-response framework of microbial pathogenesis , 2003, Nature Reviews Microbiology.

[43]  R. Aebersold,et al.  Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.

[44]  C. Gancedo,et al.  Isolation of the MIG1 Gene fromCandida albicans and Effects of Its Disruption on Catabolite Repression , 2000, Journal of bacteriology.

[45]  W. Hillen,et al.  Carbon catabolite repression in bacteria. , 1999, Current opinion in microbiology.

[46]  J. Kelly,et al.  Null alleles of creA, the regulator of carbon catabolite repression in Aspergillus nidulans. , 1997, Fungal genetics and biology : FG & B.

[47]  B. Felenbok,et al.  The Aspergillus nidulans CREA protein mediates glucose repression of the ethanol regulon at various levels through competition with the ALCR‐specific transactivator. , 1994, The EMBO journal.

[48]  J. Kelly,et al.  Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon cataboiite repression in Aspergillus nidulans , 1993, Molecular microbiology.

[49]  J. Gancedo Carbon catabolite repression in yeast. , 1992, European journal of biochemistry.

[50]  J. Kelly,et al.  Analysis of the creA gene, a regulator of carbon catabolite repression in Aspergillus nidulans , 1991, Molecular and cellular biology.

[51]  J. Kelly,et al.  Increased and decreased sensitivity to carbon catabolite repression of enzymes of acetate metabolism in mutants of Aspergillus nidulans , 1977, Molecular and General Genetics MGG.

[52]  J. Kelly,et al.  Pleiotropic mutants ofAspergillus nidulans altered in carbon metabolism , 1977, Molecular and General Genetics MGG.

[53]  H. Arst,et al.  Carbon catabolite repression in Aspergillos nidulans. , 1975, European journal of biochemistry.

[54]  Wolfgang Huber,et al.  Love MI, Huber W, Anders S.. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol 15: 550 , 2014 .

[55]  B. Philips,et al.  appearance of glucose in upper and lower respiratory tract secretions , 2003 .